ZADAXIN

Marca svizra · 436150 · Marca da pled · En vigur

Inscripziun en il register

Numer da registraziun
436150
Numer da la dumonda
13656/1995
Status
En vigur
Tip
Marca da pled
Deponida
15-12-1995
Registrada
04-02-1997
Publitgada
04-03-1997
Protegida fin ils
15-12-2035
Lingua da la procedura
tudestg
Funtauna
Swissreg

Products e servetschs

Pharmaceuticals

Pharmazeutische Präparate verwendet in der Behandlung oder zur Bereitstellung von Immunmodulationen bei viral bedingten Krankheiten, nämlich Hepatitis, Krebs und Immunschwächezuständen.

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 27-07-2025

    Prolungà

    Expiry date
    15.12.2025 → 15.12.2035

    Published in Swissreg on 27.07.2025

  2. 19-11-2024

    Publicaziun

    Published in Swissreg on 19.11.2024

  3. 03-01-2024

    Transferì

    Owner
    SciClone Pharmaceuticals International Ltd., 2nd Floor, Governors Square, Suite #5-204, 23 Lime Tree Bay Avenue, Grand Cayman, Cayman Islands, KY1-1108, Cayman Islands → SCICLONE PHARMACEUTICALS INTERNATIONAL (SG) PTE. LTD., 1 GEORGE STREET, #23-03, 049145, SINGAPORE, Singapore

    Published in Swissreg on 03.01.2024

  4. 16-10-2020

    Represchentant stritgà

    Representative
    E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich (allontanà)

    Published in Swissreg on 16.10.2020

  5. 16-10-2020

    Transferì

    Owner
    SciClone Pharmaceuticals, Inc., 950 Tower Lane, Suite 900, Foster City, CA 94404-2125, USA → SciClone Pharmaceuticals International Ltd., 2nd Floor, Governors Square, Suite #5-204, 23 Lime Tree Bay Avenue, Grand Cayman, Cayman Islands, KY1-1108, Cayman Islands
    Representative
    Meyer & Kollegen, Ringstrasse 35c, 7000 Chur

    Published in Swissreg on 16.10.2020

  6. 01-12-2015

    Adressa dal possessur midada

    Owner
    SciClone Pharmaceuticals, Inc. (a Delaware Corporation), 901 Mariners Island Blvd., San Mateo, CA 94404, USA → SciClone Pharmaceuticals, Inc., 950 Tower Lane, Suite 900, Foster City, CA 94404-2125, USA

    Published in Swissreg on 01.12.2015

  7. 01-12-2015

    Prolungà

    Published in Swissreg on 01.12.2015

  8. 03-12-2007

    Adressa dal represchentant midada

    Representative
    E. Blum & Co., Patentanwälte VSP, Vorderberg 11, 8044 Zürich → E. Blum & Co. AG, Patent- und Markenanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in the SOGC no. 234 of 03.12.2007

4 endataziuns pli veglias
  1. 26-09-2005

    Prolungà

    Published in the SOGC no. 186 of 26.09.2005

  2. 21-03-2005

    Transferì

    Owner
    SciClone Pharmaceuticals, Inc., 901 Mariners Island Blvd., San Mateo (CA 94404), USA → SciClone Pharmaceuticals, Inc. (a Delaware Corporation), 901 Mariners Island Blvd., San Mateo, CA 94404, USA
    Representative
    E. Blum & Co., Patentanwälte, Am Vorderberg 11, 8044 Zürich → E. Blum & Co., Patentanwälte VSP, Vorderberg 11, 8044 Zürich

    Published in the SOGC no. 56 of 21.03.2005

  3. 08-01-2001

    Stritgà per part

    LGS
    5, Pharmazeutische Präparate für den Gebrauch in der Behandlung von infektiösen Krankheiten, Krebs und Störungen des Immunsystems. → 5, Pharmazeutische Präparate verwendet in der Behandlung oder zur Bereitstellung von Immunmodulationen bei viral bedingten Krankheiten, nämlich Hepatitis, Krebs und Immunschwächezuständen.
    International classification
    5 → 5

    Published in the SOGC no. 4 of 08.01.2001

  4. 04-03-1997

    Registrà

    Published in the SOGC no. 42 of 04.03.1997

Partidas

Possessura

SCICLONE PHARMACEUTICALS INTERNATIONAL (SG) PTE. LTD.

1 GEORGE STREET, #23-03, 049145, SINGAPORE, SG

Represententa

Meyer & Kollegen

Ringstrasse 35c, 7000 Chur

Il register numna mintga partida cun num ed adressa. Ina partida è colliada cun ina unitad, sch’exactamain ina unitad dal register da commerzi porta ses num; la via d’ina partida betg uschia renconuschida na vegn betg mussada qua.